Is the performance too good triggering valuation controversy?Kehua Bio angers its subsidiaries for not cooperating with audits丨Information Focus

At the end of each year and the beginning of the next year, there will always be a wave of thunderstorms for listed companies. This year, such signs reappeared. Yesterday night, the leading biochemical diagnostic company Kehua Biological suddenly announced that its controlling subsidiary Tianlong Company did not cooperate with the audit work and ignored the interests of listed companies and their small and medium shareholders. The company expressed its strongest indignation and condemnation. Kehua Biological believes that the so-called “reasons” put forward by Tianlong in the “Audit Work Reply Letter” completely lack factual and legal basis.